Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris

Journal of Biosciences

Volumn 39, Issue 3, 2014, Pages 443-451

  Subathra, Murugan ^a   Santhakumar, Ponsekaran ^b   Narasu, Mangamoori Lakshmi ^a   Beevi, Syed Sultan ^a   Lal, Sunil K ^c  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^b Indian Immunologicals Limited   (India)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Enzyme linked immunosorbent assay; highly pathogenic avian influenza; immunogenicity; neuraminidase; neuraminidase inhibition

Indexed keywords

VIRUS SIALIDASE; INFLUENZA VACCINE; RECOMBINANT PROTEIN; SIALIDASE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ALUMINUM OXIDE; ANTIBODY; ANTIGEN; AVIAN INFLUENZA; BIOCHEMISTRY; ENZYME; EPIDEMIC; IMMUNOASSAY; RODENT; VACCINE; YEAST;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; MOUSE; NEURAMINIDASE GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PROTEIN EXPRESSION; VIRUS GENE; VIRUS STRAIN; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MOLECULAR CLONING; PICHIA;

AVES; MUS; PICHIA PASTORIS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; NEURAMINIDASE; PICHIA; RECOMBINANT PROTEINS;

EID: 84904114208     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-014-9422-3     Document Type: Article

References (38)

1. Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Robbins JB and Keith JM 2009 Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine 27 6234-6238
2. Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X and Varadarajan R 2010 Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc. Natl. Acad. Sci. USA 107 13701-13706
3. Brett IC and Johansson BE 2005 Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339 273-280 (Pubitemid 41169794)
4. Cereghino JL and Cregg JM 2000 Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24 45-66 (Pubitemid 30047114)
5. Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa TK, Matsuo KT, Kurata T and Tamura S 2000 Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18 3214-3222 (Pubitemid 30408197)
6. Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T and Tamura S 1999 Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. Vaccine 17 653-659
7. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, et al. 2005 Human disease from influenza A (H5N1), Thailand. Emerg. Infect. Dis. 11 201-209 (Pubitemid 40239235)
8. Deroo T, Min Jou W and Fiers W 1996 Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14 561-569 (Pubitemid 26173757)
9. Ehrlich HJ, Singer J, Berezuk G, Fritsch S, Aichinger G, Hart MK, El-Amin W, Portsmouth D, Kistner O and Barrett PN 2012 A Cell culture - derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals. Clin. Infect. Dis. 54 946-954
10. Fang F, Cai XQ, Chang HY, Wang HD, Yang ZD and Chen Z 2008 Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice. Acta Virologica 52 107-112 (Pubitemid 351879972)
11. Fedson DS 2008 NEW technologies for meeting the global demand for pandemic influenza vaccines. Biologicals: J. Int. Assn. Biol. Standard. 36 346-349 (Pubitemid 50243941)
12. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B and Osterhaus AD 2005 Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79 2814-2822 (Pubitemid 40270559)
13. Johansson BE 1999 Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17 2073-2080 (Pubitemid 29172380)
14. Johansson BE, Price PM and Kilbourne ED 1995 Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine 13 841-845
15. Keitel WA, Cate TR, Atmar RL, Turner CS, Nino D, Dukes CM, Six HR and Couch RB, 1996 Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin. Diagn. Lab. Immunol. 3 507-510 (Pubitemid 26326274)
16. Kilbourne ED, Pokorny BA, Johansson B, Brett I, Milev Y and Matthews JT 2004 Protection of mice with recombinant influenza virus neuraminidase J. Infect. Dis. 189 459-461 (Pubitemid 38210582)
17. Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y and Webster RG 1999 DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73 2094-2098 (Pubitemid 29098113)
18. Kodihalli S, Haynes JR, Robinson HL and Webster RG 1997 Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 71 3391-3396 (Pubitemid 27172347)
19. Lin GJ, Deng MC, Chen ZW, Liu TY, Wu CW, Cheng CY, Chien MS and Huang C 2012 Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine 30 2336-2341
20. Martinet W, Saelens X, Deroo T, Neirynck S, Contreras R, Min Jou W and Fiers W 1997 Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur. J. Biochem. 247 332-338 (Pubitemid 27319521)
21. Mather KA, White JF, Hudson PJ and McKimm-Breschkin JL 1992 Expression of influenza neuraminidase in baculovirus-infected cells. Virus Res. 26 127-139
22. Robinson HL, Hunt LA and Webster RG 1993 Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 957-960 (Pubitemid 23218805)
23. Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, et al. 2013 Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. J. Virol. 87 3053-3061.
24. Saelens X, Vanlandschoot P, Martinet W, Maras M, Neirynck S, Contreras R, Fiers W and Jou WM 1999 Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. Eur. J. Biochem. 260 166-175 (Pubitemid 29095707)
25. Schelleken, H, de Reus A, Peetermans JH and van Eerd PA 1987 The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen. Postgrad. Med. J.63 93-96 (Pubitemid 17094406)
26. Shi W, Lei F, Zhu C, Sievers F and Higgins DG 2010 A Complete Analysis of HA and NA Genes of Influenza A Viruses. PLoS One 5 e14454
27. Steel J, Lowen AC Wang TT, Yondola M, Gao Q, Haye K, Garcia-Sastre A and Palese P 2010 Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1 e00018-10
28. Stephenson I, Nicholson KG, Wood JM, Zambon MC and Katz JM 2004 Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect. Dis. 4 499-509 (Pubitemid 39077920)
29. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, et al. 1998 Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 393-396 (Pubitemid 28063376)
30. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, Le HN, Nguyen KT, et al. 2004 Avian influenza A (H5N1) in 10 patients in Vietnam. New Engl. J. Med. 350 1179-1188
31. Tsvetkova IV and Lipkind MA 1968 Studies on the role of myxovirus neuraminidase in virus-cell receptors interaction by means of direct determination of sialic acid split from cells. I. Experiments on influenza virus-RBC cell system. Archiv fur dies Gesamte Virusforschung 23 299-312
32. Weaver EA, Rubrum AM, Webby RJ and Barry MA 2011 Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS one 6 e18314
33. Webster RG, Fynan EF, Santoro JC and Robinson H 1994 Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12 1495-1498 (Pubitemid 24360561)
34. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ and Wiley DC 1988 Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333 426-431
35. Wood JM and Robertson JS 2004 From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. Nat. Rev. Microbiol. 2 842-827
36. World Health Organization 2013 Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003 - 2013 (Geneva: WHO) (http://www.who.int/influenza/human-animal-interface/H5N1-cumulative-table- archives/en/index.html)
37. Yang YL, Chang SH, Gong X, Wu J and Liu B 2012 Expression, purification and characterization of low-glycosylation influenza neuraminidase in α-1,6-mannosyltransferase defective Pichia pastoris. Mol. Bio. Rep. 39 857-864
38. Yongkiettrakul S, Boonyapakron K, Jongkaewwattana A, Wanitchang A, Leartsakulpanich U, Chitnumsub P, Eurwilaichitr L and Yuthavong Y 2009 Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J. Virol. Methods 156 44-51